Simple view
Full metadata view
Authors
Statistics
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor
Journal
Leukemia and Lymphoma
70
Author
Volume
62
Number
14
Pages
3440-3451
ISSN
1042-8194
eISSN
1029-2403
Access date
2022-02-01
Language
English
Journal language
English
Affiliation
Wydział Lekarski : Klinika Hematologii
Scopus© citations
16
| dc.affiliation | Wydział Lekarski : Klinika Hematologii | pl |
| dc.cm.date | 2022-04-08T06:19:19Z | |
| dc.cm.id | 105798 | pl |
| dc.cm.idOmega | UJCM7a2a5fdfbcd5426bb566f019bcc84208 | pl |
| dc.contributor.author | Staber, Philipp Bernhard | pl |
| dc.contributor.author | Jurczak, Wojciech - 129923 | pl |
| dc.contributor.author | Greil, Richard | pl |
| dc.contributor.author | Vucinic, Vladan | pl |
| dc.contributor.author | Middeke, Jan Moritz | pl |
| dc.contributor.author | Montillo, Marco | pl |
| dc.contributor.author | Munir, Talha | pl |
| dc.contributor.author | Neumeister, Peter | pl |
| dc.contributor.author | Schetelig, Johannes | pl |
| dc.contributor.author | Stilgenbauer, Stephan | pl |
| dc.contributor.author | Striebel, Frank | pl |
| dc.contributor.author | Dirnberger-Hertweck, Maren | pl |
| dc.contributor.author | Weirather, Johannes | pl |
| dc.contributor.author | Brugger, Wolfram | pl |
| dc.contributor.author | Kelemen, Peter | pl |
| dc.contributor.author | Wendtner, Clemens-Martin | pl |
| dc.contributor.author | Woyach, Jennifer Ann | pl |
| dc.date.accession | 2022-02-01 | pl |
| dc.date.accessioned | 2022-04-08T06:19:19Z | |
| dc.date.available | 2022-04-08T06:19:19Z | |
| dc.date.issued | 2021 | pl |
| dc.description.number | 14 | pl |
| dc.description.physical | 3440-3451 | pl |
| dc.description.volume | 62 | pl |
| dc.identifier.doi | 10.1080/10428194.2021.1964020 | pl |
| dc.identifier.eissn | 1029-2403 | pl |
| dc.identifier.issn | 1042-8194 | pl |
| dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/290233 | |
| dc.language | eng | pl |
| dc.language.container | eng | pl |
| dc.rights | Dodaję tylko opis bibliograficzny | * |
| dc.rights.licence | Bez licencji otwartego dostępu | |
| dc.rights.uri | * | |
| dc.source.integrator | false | |
| dc.subtype | Article | pl |
| dc.title | Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor | pl |
| dc.title.journal | Leukemia and Lymphoma | pl |
| dc.type | JournalArticle | pl |
| dspace.entity.type | Publication |
dc.affiliationpl
Wydział Lekarski : Klinika Hematologii dc.cm.date
2022-04-08T06:19:19Z dc.cm.idpl
105798 dc.cm.idOmegapl
UJCM7a2a5fdfbcd5426bb566f019bcc84208 dc.contributor.authorpl
Staber, Philipp Bernhard dc.contributor.authorpl
Jurczak, Wojciech - 129923 dc.contributor.authorpl
Greil, Richard dc.contributor.authorpl
Vucinic, Vladan dc.contributor.authorpl
Middeke, Jan Moritz dc.contributor.authorpl
Montillo, Marco dc.contributor.authorpl
Munir, Talha dc.contributor.authorpl
Neumeister, Peter dc.contributor.authorpl
Schetelig, Johannes dc.contributor.authorpl
Stilgenbauer, Stephan dc.contributor.authorpl
Striebel, Frank dc.contributor.authorpl
Dirnberger-Hertweck, Maren dc.contributor.authorpl
Weirather, Johannes dc.contributor.authorpl
Brugger, Wolfram dc.contributor.authorpl
Kelemen, Peter dc.contributor.authorpl
Wendtner, Clemens-Martin dc.contributor.authorpl
Woyach, Jennifer Ann dc.date.accessionpl
2022-02-01 dc.date.accessioned
2022-04-08T06:19:19Z dc.date.available
2022-04-08T06:19:19Z dc.date.issuedpl
2021 dc.description.numberpl
14 dc.description.physicalpl
3440-3451 dc.description.volumepl
62 dc.identifier.doipl
10.1080/10428194.2021.1964020 dc.identifier.eissnpl
1029-2403 dc.identifier.issnpl
1042-8194 dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/290233 dc.languagepl
eng dc.language.containerpl
eng dc.rights*
Dodaję tylko opis bibliograficzny dc.rights.licence
Bez licencji otwartego dostępu dc.rights.uri*
dc.source.integrator
false dc.subtypepl
Article dc.titlepl
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor dc.title.journalpl
Leukemia and Lymphoma dc.typepl
JournalArticle dspace.entity.type
Publication Affiliations
No affiliation
Staber, Philipp Bernhard
Jurczak, Wojciech
Greil, Richard
Vucinic, Vladan
Middeke, Jan Moritz
Montillo, Marco
Munir, Talha
Neumeister, Peter
Schetelig, Johannes
Stilgenbauer, Stephan
Striebel, Frank
Dirnberger-Hertweck, Maren
Weirather, Johannes
Brugger, Wolfram
Kelemen, Peter
Wendtner, Clemens-Martin
Woyach, Jennifer Ann
* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.
Views
15
Views per month
Views per city
Ashburn
2
Krakow
2
Tokyo
2
Wroclaw
2
Beijing
1
Calgary
1
Dublin
1
Lappeenranta
1
Royal Leamington Spa
1
No access
No Thumbnail Available